Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors
The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R2, R4, X1A, X2A, X1B, X2B, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compos...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
26.04.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides compounds having the formula: wherein A-B together represent one of the following structures: wherein one of is a double bond, as valency permits; and R2, R4, X1A, X2A, X1B, X2B, L1, L2, Y and Z are as defined in classes and subclasses herein, and pharmaceutical compositions thereof, as described generally and in subclasses herein, which compounds are useful as inhibitors of protein kinase (e.g., Aurora), and thus are useful, for example, for the treatment of Aurora mediated diseases. |
---|---|
Bibliography: | Application Number: US20060490983 |